MAISIE HOANG: Open Payments
NPI 1275266173 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 59 payments from 24 companies in 2025. Trend: 2023 $729 · 2024 $127 · 2025 $1,263
Food & beverage: $1,263
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $168 |
| AstraZeneca Pharmaceuticals LP | 8 | $165 |
| Astellas Pharma US Inc | 5 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| Merck Sharp & Dohme LLC | 4 | $69 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Eisai Inc. | 2 | $46 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $42 |
Products named: Veozah, FARXIGA, Leqembi, KESIMPTA, AIRSUPRA, SPRAVATO, CAPVAXIVE, ELIQUIS.
Industry payments across GA — which companies pay providers there.
